Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Radiology: Imaging Cancer is Scopus-indexed (Q2, CiteScore 4.8), WoS ESCI. Published by Radiological Society of North America Inc..
Checked against the index lists dated .
ISSN 2638-616XVerify ISSN ↗
Publisher: Radiological Society of North America Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 101 / 361 | 72nd | Q2 |
| Oncology | 167 / 428 | 61st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 4.8.
Radiology: Imaging Cancer is Q2 in Radiology, Nuclear Medicine and Imaging (rank 101 of 361) and Q2 in Oncology (rank 167 of 428), by CiteScore 2025.
Radiology: Imaging Cancer is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.8, which places it in quartile Q2 at the 72nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.082, quartile Q1, with an H-index of 30.
Radiology: Imaging Cancer is published by Radiological Society of North America Inc. Its ISSN is 2638-616X.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Radiology: Imaging Cancer has an h-index of 33 and a 2-year mean of 2.14 citations per paper (OpenAlex). Its Scopus CiteScore is 4.8, quartile Q2. On 2-year citations it ranks #106 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Radiology: Imaging Cancer published 156 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 78 research articles (2026), authors are most often from China (40%), United States (30%) and India (4.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.